骨桥蛋白、血管内皮生长因子-A和乏氧诱导因子-1α在肝细胞癌中的表达及意义

郑艳; 张春清; 王启志; 黄海燕; 王智娜; 魏源; 徐安涛

骨桥蛋白、血管内皮生长因子-A和乏氧诱导因子-1α在肝细胞癌中的表达及意义

山东省立医院东院消化内科

基金项目:

山东省自然基金科技专项(Y2007C068)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 3372
- HTML全文浏览量: 13
- PDF下载量: 668
- 被引次数: 0
出版历程
- 出版日期: 2013-01-20

Differential expression of OPN, VEGF-A, and HIF-1α and its clinical significance in hepatocellular carcinoma

Research funding:

摘要

摘要:
目的探讨骨桥蛋白（OPN）、血管内皮生长因子-A（VEGF-A）和乏氧诱导因子（HIF）-1α在肝细胞癌（HCC）中的表达及临床意义。方法采用免疫组织化学法检测肝癌组（90例）、癌旁肝硬化组（20例）及正常组（15例）中OPN、VEGF-A和HIF-1α的表达。结果 OPN、VEGF-A和HIF-1α在HCC组呈明显高表达,阳性率分别为76.67%（69/90）、71.11%（64/90）和73.33%（66/90）。其中OPN、VEGF-A显著高于癌旁肝硬化组及正常组,HIF-1α在HCC组的表达与肝硬化组无差异,与正常组有显著差异。OPN、VEGF-A、HIF-1α的表达与肝癌的临床病理特征如癌栓形成、包膜完整性、肿瘤分化和分期、肿瘤转移等有相关性（P<0.05）,三者之间表达呈正相关性（P<0.05）。结论 OPN、VEGF-A、HIF-1α在肝癌中高表达,联合检测有助于判断肝癌的生物学特征,为肝癌的分子靶向治疗提供重要的可能靶点。
- 骨桥蛋白质 /
- 血管内皮生长因子A /
- 缺氧诱导因子1,α亚基 /
- 肝肿瘤 /
- 肝硬化
Abstract:
Objective To investigate the expression patterns of osteopontin (OPN) , vascular endothelial growth factor-A (VEGF-A) , and hypoxia-inducible factor-1α (HIF-1α) in primary hepatocellular carcinoma (HCC) and determine the clinical significance of this differential expression profile.Methods Immunohistochemical staining of OPN, VEGF-A, and HIF-1α was carried out on primary HCC tissues from 90 patients, HCC-adjacent cirrhosis tissues from 20 of those patients, and normal liver tissues from 15 healthy controls.Correlations between expression levels and HCC clinicopathological characteristics were assessed by Spearman's correlation coefficient.Results The majority of HCC tissues showed positive immunostaining for OPN (69/90, 76.67%) , VEGF-A (64/90, 71.11%) , and HIF-1α (66/90, 73.33%) .OPN-and VEGF-A-positivity were significantly higher than the results from the cirrhosis tissues and normal tissues.HIF-1α-positivity was similar between the HCC and cirrhosis tissues, but both were significantly different from the normal tissues.The differential expressions of OPN, VEGF-A, and HIF-1α were significantly correlated with tumor thrombus, capsular integrity, tumor differentiation and stage, and metastasis (P<0.05) .Conclusion HCC tissues overexpress OPN, VEGF-A, and HIF-1α and this differential profile may be related to HCC progression.Future investigations of this triad of factors may provide novel insights into the biological characteristics of HCC and reveal important targets of molecular therapy.
- osteopontin /
- vascular endothelial growth factor A /
- hypoxia-inducible factor 1 /
- alpha subnit /
- liver neoplasms

HTML全文

参考文献(14)

[1]EI-Serg HB, Rudolph KL.Hepatocellular carcinoma:Epide-miology and molecular carcinogensis[J].Gastroenterology, 2007, 132:2557-2576.

[2]Guo JH, Zhu X, Li XT.Impact of serum vascular endothelialgrowth factor on prognosis in patients with unresectable HCCafter TACE[J], Chin J cancer Res, 2012, 24 (1) :36-43.

[3]Rosivatz E, Becker I, Specht K, et al.Differential expressionof the epithelial-mesenchymal transition regulators Snail, SIP1, and twist in gastric cancer[J].Am J Pathol, 2002, 161 (5) :1881-1891.

[4]Senger DR, Wirth DF, Hynes Ro.Transformed mammaliancells secrete specific proteins and phosphoproteins[J].Cell, 1979, 16:885-893.

[5]Chung J, Yoon SO, Lipscomb EA, et al.The Met receptorand alpha 6 beta 4 integrin can function independently to pro-mote carcinoma invasion[J].J Biol chem, 2004, 279 (31) :32287-32293.

[6]Gao C, Guo H, Downey L, et al.Osteopontin-dependentCD44v6 expression and cell adhesion in HepG2 cells[J].Carcinogenesis, 2003, 24 (12) :187l-1878.

[7]Guo H, Marroquin CE, Wai PY, et al.Nitric oxide-depend-ent osteopontin expression induces metastatic behavior inHepG2 cells[J].Dig Dis Sci, 2005, 50 (7) :1288-1298.

[8]Zhang Gx, Zhao ZQ, Wang HD, et al.Enhancement of os-teopontin expression in HepG2 cells by epidemal growth fac-tor via phosphatidylinositol 3-kinase signaling pathway[J].World J Gastroenterol, 2004, 10 (2) :205-208.

[9]Reginato MJ, Mills KR, Paulus JK, et al.Integrins and EGFRcoordinately regulate the pro-apoptotic protein Bim to pre-vent anoikis[J].Nat Cell Biol, 2003, 5 (8) :733-740.

[10]刘兵团, 张国新, 郝波, 等.骨桥蛋白在肝癌患者外周血和癌组织中的含量极其临床意义[J].江苏医药, 2007, 33 (11) :1081-1083.

[11]郜玉峰, 李旭, 谢琴秀, 等.骨桥蛋白和CD44v6在肝癌中的表达及意义[J].中华肝脏病杂志, 2005, 13 (3) :227-228.

[12]陆健, 卞建民, 樊克武, 等.肝癌中骨桥蛋白和血管内皮生长因子的表达及临床意义[J].江苏医药, 2006, 32 (5) :418-420.

[13]Cao DX, Li ZJ, Jiang XO, et al.Osteopontin as potential bio-marker and therapeutic target in gastric and liver cancers[J].World J Gastroenterol, 2012, 18 (30) :3923-3930.

[14]Suzuki S, Dobashi Y, Hatakeyama Y, et al.Clinicopathologi-cal significance of platelet-derived growth factor (PDGF) -B and vascular endothelial growth factor-A expression, PDGF receptor-βphosphorylation, and microvessel densityin gastric cancer[J].BMC Cancer, 2010, 10:659.

施引文献

资源附件(0)

访问统计